U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...

Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their ...

Democratic U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant ...

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

The presented data provides a snapshot of the financial health and recent market performance of key stocks within the NIFTY MIDCAP 150 index.

It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.

The end of production at one of pharmaceutical firm GlaxoSmithKline's (GSK) UK factories is a "sad day", a former worker has said. The site in Ulverston, Cumbria, opened more than 75 years ago and ...

U.S. Senator Maggie Hassan has initiated an investigation into GlaxoSmithKline's decision to discontinue the Flovent HFA ...

The global vitamin D therapy market was valued at approximately USD 4.59 billion in 2022 and is projected to grow at an impressive growth rate of around 11.6% over the forecast period from 2023 to ...